Cell- and Tissue-Based Therapy

"Cell- and Tissue-Based Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Therapies that involve the TRANSPLANTATION of CELLS or TISSUES developed for the purpose of restoring the function of diseased or dysfunctional cells or tissues.

Descriptor ID	D064987
MeSH Number(s)	E02.095.147
Concept/Terms	Cell- and Tissue-Based Therapy Cell- and Tissue-Based Therapy Cell and Tissue Based Therapy Tissue Therapy Tissue Therapy Therapy, Tissue Cell Therapy Cell Therapy Therapy, Cell

Below are MeSH descriptors whose meaning is more general than "Cell- and Tissue-Based Therapy".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Therapeutics [E02]
Biological Therapy [E02.095]
Cell- and Tissue-Based Therapy [E02.095.147]

Below are MeSH descriptors whose meaning is related to "Cell- and Tissue-Based Therapy".

Below are MeSH descriptors whose meaning is more specific than "Cell- and Tissue-Based Therapy".

Cell- and Tissue-Based Therapy
Cell Transplantation
Tissue Transplantation

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Cell- and Tissue-Based Therapy" by people in this website by year, and whether "Cell- and Tissue-Based Therapy" was a major or minor topic of these publications.

Bar chart showing 26 publications over 13 distinct years, with a maximum of 4 publications in 2024

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2005	1	0	1
2008	1	0	1
2013	1	1	2
2014	1	1	2
2015	1	1	2
2016	2	1	3
2017	1	0	1
2018	0	1	1
2019	2	0	2
2020	1	1	2
2021	1	2	3
2022	0	2	2
2024	2	2	4

Below are the most recent publications written about "Cell- and Tissue-Based Therapy" by people in Profiles.

Dobruskin M, Toner G, Kander R. Optimizing cryopreservation strategies for scalable cell therapies: A comprehensive review with insights from iPSC-derived therapies. Biotechnol Prog. 2024 Nov-Dec; 40(6):e3504.

View in: PubMed
Kalavar M, Lovett EA, Nicholas MP, Ross-Hirsch A, Nirwan RS, Sridhar J, Patel S, Flynn HW, Albini TA, Kuriyan AE. Update on "Cell Therapy" Clinics Offering Treatments of Ocular Conditions Using Direct-To-Consumer Marketing Websites in the U.S. Am J Ophthalmol. 2024 Nov; 267:135-141.

View in: PubMed
Gardner RA, White C, Elsallab M, Farnia S, Fraint E, Grilley B, Bateman-House A, Grupp SA, Kenderian S, Locke FL, Nikiforow S, Oluwole OO, Rouce RH, Spiegel J, Shah NN, Sharma A, Komanduri K, Gill S. ACT To Sustain: Adoptive Cell Therapy To Sustain Access to Non-Commercialized Genetically Modified Cell Therapies. Transplant Cell Ther. 2024 08; 30(8):776-787.

View in: PubMed
Zhang ZH, Barajas-Martinez H, Jiang H, Huang CX, Antzelevitch C, Xia H, Hu D. Gene and stem cell therapy for inherited cardiac arrhythmias. Pharmacol Ther. 2024 04; 256:108596.

View in: PubMed
Nath K, Tomas AA, Flynn J, Fein JA, Alperovich A, Anagnostou T, Batlevi CL, Dahi PB, Fingrut WB, Giralt SA, Lin RJ, Palomba ML, Peled JU, Salles G, Sauter CS, Scordo M, Fraint E, Feuer E, Shah N, Slingerland JB, Devlin S, Shah GL, Gupta G, Perales MA, Shouval R. Vitamin D Insufficiency and Clinical Outcomes with Chimeric Antigen Receptor T-Cell Therapy in Large B-cell Lymphoma. Transplant Cell Ther. 2022 11; 28(11):751.e1-751.e7.

View in: PubMed
Roy I, Smilnak G, Burkart M, Hamilton E, Thorp K, Miyata S, Ma S, Pro B, Winter J, Gordon L, Karmali R. Cachexia is a risk factor for negative clinical and functional outcomes in patients receiving chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma. Br J Haematol. 2022 04; 197(1):71-75.

View in: PubMed
Hinkle JW, Mahmoudzadeh R, Kuriyan AE. Cell-based therapies for retinal diseases: a review of clinical trials and direct to consumer "cell therapy" clinics. Stem Cell Res Ther. 2021 10 11; 12(1):538.

View in: PubMed
Banerjee R, Shah N, Dicker AP. Next-Generation Implementation of Chimeric Antigen Receptor T-Cell Therapy Using Digital Health. JCO Clin Cancer Inform. 2021 06; 5:668-678.

View in: PubMed
Mahmoudzadeh R, Hinkle JW, Hsu J, Garg SJ. Emerging treatments for geographic atrophy in age-related macular degeneration. Curr Opin Ophthalmol. 2021 May 01; 32(3):294-300.

View in: PubMed
Benor A, Gay S, DeCherney A. An update on stem cell therapy for Asherman syndrome. J Assist Reprod Genet. 2020 Jul; 37(7):1511-1529.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement